Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met
These outcomes could transition to us successfully, but most human evidence is anecdotal
Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, et al
Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis
Based on current timelines, FDA submission could occur in 2026-2027 with potential approval in 2027-2028
Powers Wj Fau -, Rabinstein AA, Rabinstein Aa Fau - Ackerson T, Ackerson T, Fau - Adeoye OM, Adeoye Om Fau - Bambakidis NC, Bambakidis Nc Fau -, Becker K, Becker K, Fau - Biller J et al
US$ 22.02
US$ 21.21
US$ 29.13
US$ 29.10
US$ 24.24
